Holen Sie sich die Stockscreener-App
31.42
20.89%
5.43
Schlusskurs vom Vortag:
$25.99
Offen:
$26.93
24-Stunden-Volumen:
845.83K
Relative Volume:
1.85
Marktkapitalisierung:
$911.44M
Einnahmen:
$219.79M
Nettoeinkommen (Verlust:
$-57.47M
KGV:
-14.61
EPS:
-2.15
Netto-Cashflow:
$-19.25M
1W Leistung:
+30.10%
1M Leistung:
+38.29%
6M Leistung:
+62.38%
1J Leistung:
-6.60%
1-Tages-Spanne:
$26.01
$31.71
1-Wochen-Bereich:
$23.46
$31.71
52-Wochen-Spanne:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
Firmenname
Castle Biosciences Inc
Sektor
Branche
Telefon
866-788-9007
Adresse
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Vergleichen Sie CSTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
31.42 | 753.93M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
563.70 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.84 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.43 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.99 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
211.90 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-04-30 | Eingeleitet | Lake Street | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Bestätigt | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | BTIG Research | Buy |
| 2019-08-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
CSTL: Analyst Baird Raises Price Target on Castle Biosciences | - GuruFocus
Castle Biosciences Inc. recovery potential after sell off2025 Support & Resistance & Stock Market Timing Techniques - newser.com
symbol__ Stock Quote Price and Forecast - CNN
Pattern recognition hints at Castle Biosciences Inc. upsideShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Risk adjusted return profile for Castle Biosciences Inc. analyzedMarket Risk Summary & Capital Protection Trade Alerts - newser.com
Transcript : Castle Biosciences, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Castle Biosciences (CSTL) Reports Strong Q3 Revenue Surge - GuruFocus
Earnings call transcript: Castle Biosciences Q3 2025 beats revenue forecast By Investing.com - Investing.com Australia
Earnings call transcript: Castle Biosciences Q3 2025 beats revenue forecast - Investing.com
Castle Biosciences revenue hits 83 million in Q3 amid 36 percent test surge - Traders Union
Castle Biosciences (CSTL) Boosts 2025 Revenue Guidance - GuruFocus
Castle Biosciences Ups Guidance As New Tests Drive Growth - Finimize
Castle Biosciences Inc (CSTL) Q3 2025 Earnings: Revenue Surpasses Estimates at $83M, EPS Loss Narrows to $0.02 - GuruFocus
Castle Biosciences Reports Third Quarter 2025 Results - Bluefield Daily Telegraph
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide - GlobeNewswire
Chart based analysis of Castle Biosciences Inc. trendsJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Full technical analysis of Castle Biosciences Inc. stockTreasury Yields & AI Powered Trade Plan Recommendations - newser.com
Will Castle Biosciences Inc. stock remain a Wall Street favoriteLong Setup & Entry Point Confirmation Signals - newser.com
Is Castle Biosciences Inc. stock a dividend growth opportunity2025 Big Picture & Entry Point Confirmation Signals - newser.com
Why hedge funds are buying Castle Biosciences Inc. stockBond Market & Capital Efficiency Focused Ideas - newser.com
Is Castle Biosciences Inc. stock attractive for income investorsInsider Buying & Comprehensive Market Scan Insights - newser.com
Quantitative breakdown of Castle Biosciences Inc. recent moveMarket Risk Report & Real-Time Market Trend Scan - newser.com
Statistical indicators supporting Castle Biosciences Inc.’s strengthJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Y Intercept Hong Kong Ltd Buys Shares of 78,938 Castle Biosciences, Inc. $CSTL - MarketBeat
When is the best time to exit Castle Biosciences Inc.Weekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Evaluating Castle Biosciences Inc. with trendline analysisQuarterly Profit Report & Daily Profit Focused Screening - newser.com
Castle Biosciences (NASDAQ:CSTL) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
What technical signals suggest for Castle Biosciences Inc. stockWeekly Profit Report & Technical Analysis for Trade Confirmation - newser.com
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Report Preview: W - GuruFocus
Zacks.com featured highlights include RadNet, Mission Produce, Castle Biosciences and FreightCar America - sharewise.com
Earnings visualization tools for Castle Biosciences Inc.Quarterly Profit Summary & Short-Term Trading Alerts - newser.com
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
6.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):